Thank you to those that joined us for our first R&D Webinar. We had a great response and an engaged audience. For those that missed it, you can view the full recording via the link below. Topics covered on the day included:
- The strong science behind HXP124 and how R&D is illuminating the potential of HXP124 as a new and attractive treatment for onychomycosis;
- The unique properties of HXP124 and why it is potentially an ideal solution for a large and poorly served market;
- An introduction to our Scientific Advisory Board and their support for HXP124’s development as a new therapy for onychomycosis.
View R&D Webinar recording here → R&D Recording
